Regeneron Pharmaceuticals | REGN - Operating Profit

Stock Price
762.98
Daily Change
1.13 0.15%
Monthly
-2.38%
Yearly
33.21%
Q2 Forecast
738.92

Regeneron Pharmaceuticals reported $898.6M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
AbbVie USD 5.81B 1.23B Dec/2025
Agenus USD 14.4M 19.26M Dec/2025
Agios Pharmaceuticals USD -121.58M 4.71M Dec/2025
Alnylam Pharmaceuticals USD 29.4M 59.36M Dec/2025
Amgen USD 3.96B 464M Dec/2025
Astellas Pharma JPY 134.54B 30.13B Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Biogen USD 659.6M 192.2M Sep/2025
BioMarin Pharmaceutical USD 198.39M 230.08M Dec/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Incyte USD 383.88M 47.43M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Kyowa Hakko Kirin JPY 38.35B 12.49B Dec/2025
Merck USD 6.24B 318M Dec/2025
Moderna USD -857M 597M Dec/2025
Neurocrine Biosciences USD 227.9M 11.4M Dec/2025
Novartis USD 4.06B 437M Dec/2025
Novartis USD 4.06B 521M Dec/2025
Pfizer USD 4.65B 3.99B Dec/2025
Puma Biotechnology USD 22.08M 24.26M Sep/2024
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.5B 2.29B Dec/2025
Sarepta Therapeutics USD -410.08M 347.2M Dec/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025
Ultragenyx Pharmaceutical USD -114M 56.89M Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Vertex Pharmaceuticals USD 1.26B 24.5M Dec/2025